Abstract
Human ‘multipotent mesenchymal stromal cells’ (hMSCs) are popular cells in human regenerative medicine due to their ability to renew themselves and differentiate into various specialized cell types under specific physiological or experimental conditions. HMSCs secrete a broad spectrum of components including proteins and metabolites that represent significant effects on the cells in their neighborhood. Furthermore, it assists to characterize them. The therapeutic effects of hMSCs were thought to be due to their multipotent characterization and their ability to engraft and differentiate at the site of injury. However, recent studies have revealed the fact that a secretome plays important role in the therapeutic potential of hMSCs. Here, we outline the decoding of the metabolome for hMSCs secretome through metabolic profiling by application of MALDI-TOF-MS which could contribute to a better understanding of the therapeutic effects associated with hMSCs and their characterization.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mendicino M, Bailey AM, Wonnacott K, Puri RK, Bauer SR. MSC-based product characterization for clinical trials: an FDA perspective. Cell Stem Cell. 2014;14(2):141–5.
Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell. 2008;2(4):313–9.
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause DS, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315–7.
Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol. 2004;36(4):568–84.
Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143–7.
Lai RC, Yeo RWY, Tan SS, Zhang B, Yin Y, Sze NSK, et al. Mesenchymal stem cell exosomes: the future msc-based therapy? In: Mesenchymal stem cell therapy. Totowa: Humana Press; 2013. p. 39–61.
Giordano A, Galderisi U, Marino IR. From the laboratory bench to the patient’s bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol. 2007;211(1):27–35.
Afanasyev BV, Elstner EE, Zander AR. A. J. Friedenstein, founder of the mesenchymal stem cell concept. Cell Ther Transplant. 2009;1(3):35–8.
Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation. 1974;17(4):331–40.
Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 1968;6(2):230–47. [cited 2018 Aug 5].
Ullah I, Subbarao RB, Rho GJ. Human mesenchymal stem cells - current trends and future prospective. Biosci Rep. 2015;35(2):e00191.
Hass R, Kasper C, Böhm S, Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal. 2011;9(1):12.
Brunstein CG, Setubal DC, Wagner JE. Expanding the role of umbilical cord blood transplantation. Br J Haematol. 2007;137(1):20–35.
Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells. 2007;25(11):2896–902.
Vizoso F, Eiro N, Cid S, Schneider J, Perez-Fernandez R. Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine. Int J Mol Sci. 2017;18(9):1852.
Zimmerlin L, Park TS, Zambidis ET, Donnenberg VS, Donnenberg AD. Mesenchymal stem cell secretome and regenerative therapy after cancer. Biochimie. 2013;95(12):2235–45.
Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006;98(5):1076–84.
McNamara LE, Sjöström T, Meek RMD, Oreffo ROC, Su B, Dalby MJ, et al. Metabolomics: a valuable tool for stem cell monitoring in regenerative medicine. J R Soc Interface. 2012;9(73):1713–24.
Minai-Tehrani A, Jafarzadeh N, Gilany K. Metabolomics: a state-of-the-art technology for better understanding of male infertility. Andrologia. 2016;48(6):609–16.
Fiehn O. Metabolomics — the link between genotypes and phenotypes. In: Functional genomics. Dordrecht: Springer; 2002. p. 155–71.
Goodacre R. Metabolomics of a superorganism. J Nutr. 2007;137(1):259S–66S.
Griffin JL. The Cinderella story of metabolic profiling: does metabolomics get to go to the functional genomics ball? Philos Trans R Soc Lond Ser B Biol Sci. 2006;361(1465):147–61.
Wishart DS, Feunang YD, Marcu A, Guo AC, Liang K, Vázquez-Fresno R, et al. HMDB 4.0: the human metabolome database for 2018. Nucleic Acids Res. 2018;46(D1):D608–17.
Dando I, Dalla Pozza E, Biondani G, Cordani M, Palmieri M, Donadelli M. The metabolic landscape of cancer stem cells. IUBMB Life. 2015;67(9):687–93.
Shyh-Chang N, Ng H-H. The metabolic programming of stem cells. Genes Dev. 2017;31(4):336–46.
Murgia A, Mancuso L, Manis C, Caboni P, Cao G. GC-MS metabolomics analysis of mesenchymal stem cells treated with copper oxide nanoparticles. Toxicol Mech Methods. 2016;26(8):611–9.
Mastrangelo A, Panadero MI, Pérez LM, Gálvez BG, García A, Barbas C, et al. New insight on obesity and adipose-derived stem cells using comprehensive metabolomics. Biochem J. 2016;473(14):2187–203.
Ivanova G, Pereira T, Caseiro AR, Georgieva P, Maurício AC. Metabolomic and proteomic analysis of the mesenchymal stem cells’ secretome. In: Metabolomics - fundamentals and applications. London: InTech; 2016.
West FD, Henderson WM, Yu P, Yang J-Y, Stice SL, Smith MA. Metabolomic response of human embryonic stem cell-derived germ-like cells after exposure to steroid hormones. Toxicol Sci. 2012;129(1):9–20.
Kim J-S, Kim E-J, Kim H-J, Yang J-Y, Hwang G-S, Kim C-W. Proteomic and metabolomic analysis of H2O2-induced premature senescent human mesenchymal stem cells. Exp Gerontol. 2011;46(6):500–10.
Cezar GG, Quam JA, Smith AM, Rosa GJM, Piekarczyk MS, Brown JF, et al. Identification of small molecules from human embryonic stem cells using metabolomics. Stem Cells Dev. 2007;16(6):869–82.
Wang G, Cao K, Liu K, Xue Y, Roberts AI, Li F, et al. Kynurenic acid, an IDO metabolite, controls TSG-6-mediated immunosuppression of human mesenchymal stem cells. Cell Death Differ. 2018;25(7):1209–23.
Pan Z, Raftery D. Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics. Anal Bioanal Chem. 2007;387(2):525–7.
Cui L, Lu H, Lee YH. Challenges and emergent solutions for LC-MS/MS based untargeted metabolomics in diseases. Mass Spectrom Rev. 2018;37(6):772–92.
Brion C, Miller S. Regulated and constitutive secretion. Differential effects of protein synthesis arrest on transport of glycosaminoglycan chains to the two secretory pathways. J Biol Chem. 1992;267(3):1477–83.
Kilroy GE, Foster SJ, Wu X, Ruiz J, Sherwood S, Heifetz A, et al. Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors. J Cell Physiol. 2007;212(3):702–9.
Lee MJ, Kim J, Kim MY, Bae Y-S, Ryu SH, Lee TG, et al. Proteomic analysis of tumor necrosis factor-α-induced secretome of human adipose tissue-derived mesenchymal stem cells. J Proteome Res. 2010;9(4):1754–62.
Kupcova Skalnikova H. Proteomic techniques for characterisation of mesenchymal stem cell secretome. Biochimie. 2013;95(12):2196–211.
Camargo M, Intasqui P, Bruna de Lima C, Montani DA, Nichi M, Pilau EJ, et al. MALDI-TOF fingerprinting of seminal plasma lipids in the study of human male infertility. Lipids. 2014;49(9):943–56.
Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37(8):911–7.
Castiglione F, Ferro M, Mavroudakis E, Pellitteri R, Bossolasco P, Zaccheo D, et al. NMR metabolomics for stem cell type discrimination. Sci Rep. 2017;7(1):15808.
Gilany K, Moazeni Pouracil RS, Reza Sadeghi M. Fourier transform infrared spectroscopy: a potential technique for noninvasive detection of spermatogenesis. Avicenna J Med Biotechnol. 2014;6(1):47–52.
Gilany K, Jafarzadeh N, Mani-Varnosfaderani A, Minai-Tehrani A, Sadeghi MR, Darbandi M, et al. Metabolic fingerprinting of seminal plasma from non-obstructive azoospermia patients: positive versus negative sperm retrieval. J Reprod Infertil. 2018;19(2):109–14.
Jafarzadeh N, Mani-Varnosfaderani A, Minai-Tehrani A, Savadi-Shiraz E, Sadeghi MR, Gilany K. Metabolomics fingerprinting of seminal plasma from unexplained infertile men: a need for novel diagnostic biomarkers. Mol Reprod Dev. 2015;82:150.
Gilany K, Moazeni-Pourasil RS, Jafarzadeh N, Savadi-Shiraz E. Metabolomics fingerprinting of the human seminal plasma of asthenozoospermic patients. Mol Reprod Dev. 2014;81(1):84–6.
Zhang J, Rector J, Lin JQ, Young JH, Sans M, Katta N, et al. Nondestructive tissue analysis for ex vivo and in vivo cancer diagnosis using a handheld mass spectrometry system. Sci Transl Med. 2017;9(406):eaan3968.
Johnson CH, Ivanisevic J, Benton HP, Siuzdak G. Bioinformatics: the next frontier of metabolomics. Anal Chem. 2015;87(1):147–56.
Guijas C, Montenegro-Burke JR, Domingo-Almenara X, Palermo A, Warth B, Hermann G, et al. METLIN: a technology platform for identifying knowns and unknowns. Anal Chem. 2018;90(5):3156–64.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Gilany, K., Masroor, M.J., Minai-Tehrani, A., Mani-Varnosfaderani, A., Arjmand, B. (2019). Metabolic Profiling of the Mesenchymal Stem Cells’ Secretome. In: Arjmand, B. (eds) Genomics, Proteomics, and Metabolomics. Stem Cell Biology and Regenerative Medicine. Humana, Cham. https://doi.org/10.1007/978-3-030-27727-7_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-27727-7_3
Published:
Publisher Name: Humana, Cham
Print ISBN: 978-3-030-27726-0
Online ISBN: 978-3-030-27727-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)